194 related articles for article (PubMed ID: 36992525)
1. Inhibition of lncRNA PCAT19 promotes breast cancer proliferation.
Feng J; Zhang J; Li Y; Cheng W; Liu Y; Chen Z; Duan Y; Yu T; Hu A; Wang T; Zhang H; Li M; Rong Z; Ma F; Guo B
Cancer Med; 2023 May; 12(10):11971-11982. PubMed ID: 36992525
[TBL] [Abstract][Full Text] [Related]
2. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
3. Identification of lncRNA PCAT19 as potential novel biomarker for colorectal cancer.
Masoud A; Mohamadynejad P
Gene; 2024 Jan; 891():147828. PubMed ID: 37748628
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA PCAT19 Regulates the Malignant Progression of Bladder Cancer through the miR-335-5p/IER2 Axis.
Wang C; Jiang H
Crit Rev Eukaryot Gene Expr; 2022; 32(8):81-94. PubMed ID: 36017918
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9.
Xiao L; Yuan W; Huang C; Luo Q; Xiao R; Chen ZH
J Cancer; 2022; 13(1):102-111. PubMed ID: 34976174
[TBL] [Abstract][Full Text] [Related]
7. lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182/PDK4 axis.
Xu S; Guo J; Zhang W
J Cell Biochem; 2019 Aug; 120(8):12810-12821. PubMed ID: 30868666
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4.
Li W; Jin X; Zhao Y; Dai J; Cai Y
Pathol Res Pract; 2020 Feb; 216(2):152772. PubMed ID: 31839366
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
12. LINC00536 Promotes Breast Cancer Progression by Regulating ROCK1 via Sponging of miR-214-5p.
Hu C; Zhang X; Fang K; Guo Z; Li L
Biochem Genet; 2023 Jun; 61(3):1163-1184. PubMed ID: 36513954
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
Yue X; Wu WY; Dong M; Guo M
Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
Xu Y; Ren Z; Wang X; Ren M
J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
18. Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma.
Tang X; Hua X; Peng X; Pei Y; Chen Z
Front Genet; 2021; 12():765275. PubMed ID: 35095999
[TBL] [Abstract][Full Text] [Related]
19. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p.
Mao Q; Lv M; Li L; Sun Y; Liu S; Shen Y; Liu Z; Luo S
J Cell Physiol; 2020 Mar; 235(3):2668-2675. PubMed ID: 31490021
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
